Cancer Causes & Control

, Volume 12, Issue 10, pp 909–916 | Cite as

Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, R.O.C.)

  • How-Ran Guo
  • Hsin-Su Yu
  • Howard Hu
  • Richard R. Monson


Objective: The association between arsenic ingestion and cancer has been documented for more than a century. Previous studies showed that the carcinogenic effects of arsenic on the urinary system are cell-type specific. To evaluate whether this is also true for skin cancers, we conducted an ecological study in 243 townships in Taiwan. Methods: The arsenic exposure was assessed on the basis of measurement reports from a previous survey, and cases of skin cancer were identified using the information gathered by the National Cancer Registry Program. We analyzed the data by regression models using multiple variables to describe the exposure status, and an urbanization index was also included in the models to adjust for the effects of urbanization. Results: A total of 2369 patients with skin cancer, comprising 1415 men and 954 women, were registered between 1 January 1980 and 31 December 1989. Among the three major cell types of skin cancer, squamous cell carcinoma and basal cell carcinoma appear to be associated with ingestion of arsenic. Such an association was not observed for malignant melanoma. Conclusions: The results suggested that the carcinogenicity of arsenic on skin is cell-type specific, which is compatible with the findings in previous studies on urinary cancers.

arsenic basal cell carcinoma drinking water malignant melanoma skin cancer squamous cell carcinoma. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yeh S (1963) Relative incidence of skin cancer in Chinese in Taiwan: with special reference to arsenical cancer. Monogr Natl Cancer Inst 10: 81-107.Google Scholar
  2. 2.
    Chen K-P, Wu H-Y, Yeh C-C, Cheng Y-J (1979) Color Atlas of Cancer Mortality by Administrative and Other Classified Districts in Taiwan Area: 1968–1976. Taipei, Taiwan: National Science Council, NSC Special Publication No. 2.Google Scholar
  3. 3.
    Tseng W-P, Chu H-M, How S-H, Fong J-M, Lin C-S, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Nat Cancer Inst 40: 453-463.Google Scholar
  4. 4.
    Environmental Protection Agency (1984) Health Assessment Document for Inorganic Arsenic: Final Report. Washington, DC: US Environmental Protection Agency, EPA Publication EPA-600/8-83-022F.Google Scholar
  5. 5.
    Risk Assessment Forum (1988) Special Report on Ingested Inorganic Arsenic: Skin Cancer; Nutritional Essentiality. Washington, DC: US Environmental Protenction Agency, US EPA 625/3-87/013.Google Scholar
  6. 6.
    Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y (1985) Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan: high-arsenic artisan well water and cancers. Cancer Res 45: 5895-5899.Google Scholar
  7. 7.
    Chen C-J, Kuo T-L, Wu M-M (1988) Arsenic and cancers. Lancet 1: 414-415.Google Scholar
  8. 8.
    Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130: 1123-1132.Google Scholar
  9. 9.
    Brown KG, Chen C-J (1995) Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Analysis 15: 475-484.Google Scholar
  10. 10.
    Chen C-J, Wang C-J (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 50: 5470-5474.Google Scholar
  11. 11.
    Lo M-C, Hsen Y-C, Lin B-K (1977) Second Report on the Investigation of Arsenic Content in Underground Water in Taiwan. Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation.Google Scholar
  12. 12.
    Guo H-R, Chen C-J, Greene HL (1994) Arsenic in drinking water and Cancers: a descriptive review of Taiwan studies. In: Chappell WR, Abernathy CO, Cothern CR, eds. Arsenic: Exposure and Health. Special Issue of Environmental Geochemistry and Health, vol. 16. Northwood, UK: Science and Technology Letters, pp. 129-138.Google Scholar
  13. 13.
    Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR (1997) Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8: 545-550.Google Scholar
  14. 14.
    American Public Health Association (1985) Standard Methods of the Evaluation of Water and Water Waste. Washington, DC: American Public Health Association.Google Scholar
  15. 15.
    Greschonig H, Irgolic KJ (1995) The mercuric bromide stain method for the determination of arsenic: implications for the epidemiological studies in Taiwan. In: SEGH Second International Conference on Arsenic Exposure and Health Effects, Book of Abstracts. San Diego, CA: Society for Environmental Geochemistry and Health.Google Scholar
  16. 16.
    Guo H-R, Lipsitz SR, Hu H, Monson RR (1994) The dose-response relationship between arsenic in drinking water and skin cancers. In: Workshop on Arsenic: Epidemiology and PBPK Modeling, Book of Abstracts. Annapolis, MD: Society for Environmental Geochemistry and Health.Google Scholar
  17. 17.
    World Health Organization (1976) International Classification of Diseases for Oncology, 1st edn. Geneva: World Health Organization.Google Scholar
  18. 18.
    Guo H-R, Lipsitz SR, Hu H, Monson RR (1998) Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer. Environ Res 79: 82-93.Google Scholar
  19. 19.
    Rosenbaum PR, Rubin DB (1984) Difficulties with regression analysis of age-adjusted rates. Biometrics 40: 437-443.Google Scholar
  20. 20.
    Wu S-Y (1986) Report on the Degree of Urbanization of Precincts and Townships in Taiwan. Taipei, Taiwan: Bureau of Statistics, Executive Yuan.Google Scholar
  21. 21.
    Hutchinson J (1887) Arsenic cancer. Br Med J 2: 1280-1281.Google Scholar
  22. 22.
    Hutchinson J (1888) On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Trans Pathol Soc Lond 39: 352-363.Google Scholar
  23. 23.
    Lagerholm B, Skog E (1968) Squamous cell carcinoma in psoriasis vulgaris. Three cases of squamous cell carcinoma developing in psoriatic lesions. Acta Dermato-Venereologica 48: 128-136.Google Scholar
  24. 24.
    Southwick GJ, Schwartz RA (1979) Arsenically associated cutaneous squamous cell carcinoma with hypercalcemia. J Surg Oncol 12: 115-118.Google Scholar
  25. 25.
    Ismail R, Cheng PS (1988) Multiple Bowen's disease associated with squamous cell carcinoma — a report of a case. J Dermatol 15: 65-67.Google Scholar
  26. 26.
    Andrews PE, Farrow GM, Oesterling JE (1991). Squamous cell carcinoma of the scrotum: long-term folowup of 14 patients. J Urol 146: 1299-1304.Google Scholar
  27. 27.
    Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR (1999) Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br J Cancer 80: 1080-1086.Google Scholar
  28. 28.
    Jackson R, Grainge JW (1975) Arsenic and cancer. Can Med Assoc J 113: 396-401.Google Scholar
  29. 29.
    Bruynzeel I, Bergman W, Hartevelt HM, et al. (1991) High singledose European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 124: 49-55.Google Scholar
  30. 30.
    Huang YZ, Qian XC, Wang GQ, et al. (1992) Syndrome of endemic arsenism and fluorosis. A clinical study. Chinese Med J 105: 586-590.Google Scholar
  31. 31.
    Wagner SL, Maliner JS, Morton WE, Braman RS (1979) Skin cancer and arsenical intoxication from well water. Arch Dermatol 115: 1205-1207.Google Scholar
  32. 32.
    Roat JW, Wald A, Mendelow H, Pataki KI (1982) Hepatic angiosarcoma associated with short-term arsenic ingestion. Am J Med 73: 933-936.Google Scholar
  33. 33.
    Nakjang Y, Kullavanijaya P (1994) Basal cell carcinoma: seven years' experience at the Institute of Dermatology in Bangkok. J Dermatol 21: 660-663.Google Scholar
  34. 34.
    Mowad CM, Jaworsky C, Werth VP (1996) Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Arch Dermatol 132: 1105-1106, 1108–1109.Google Scholar
  35. 35.
    Wong SS, Tan KC, Goh CL (1998) Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 38: 179-185.Google Scholar
  36. 36.
    Kim HJ, Min HG, Lee ES (1999). Bowen's diseases and basal cell carcinomas in a patient. J Dermatol 26: 695-697.Google Scholar
  37. 37.
    Boonchai W, Walsh M, Cummings M, Chenevix-Trench G (2000) Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch Dermatol 136: 195-198.Google Scholar
  38. 38.
    Yeh S, How SW, Lin CS (1968) Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 21: 312-239.Google Scholar
  39. 39.
    Yeh S, Chen HC, How SW, Deng CS (1974) Fine structure of Bowen's disease in chronic arsenicalism. J Natl Cancer Inst 53: 31-44.Google Scholar
  40. 40.
    Upshaw CB Jr, Bryant MF, Claiborne TS Jr (1979) Noncirrhotic portal hypertension after arsenic ingestion. South Med J 72: 1332-1324.Google Scholar
  41. 41.
    Heddle R, Bryant GD (1983). Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion. Chest 84: 776-777.Google Scholar
  42. 42.
    Tan SH, Tham SN, Goh CL (1995) Skin cancers at Tertiary Referral Skin Hospital in Singapore. Int J Dermatol 34: 770-776.Google Scholar
  43. 43.
    Murata K, Iwazawa T, Takayama T, Yamashita K, Okagawa K (1994) Quadruple cancer including Bowen's disease after arsenic injections 40 years earlier: report of a case. Surg Today 24: 1115-1118.Google Scholar
  44. 44.
    Ohnishi Y, Murakami S, Ohtsuka H, Miyauchi S, Shinmori H, Hashimoto K (1997) Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure? J Dermatol 24: 310-316.Google Scholar
  45. 45.
    Tsuruta D, Hamada T, Mochida K, Nakagawa K, Kobayashi H, Ishii M (1998) Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning. Br J Dermatol 139: 291-294.Google Scholar
  46. 46.
    Lien HC, Tsai TF, Lee YY, Hsiao CH (1999) Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol 41: 641-643.Google Scholar
  47. 47.
    Shneidman D, Belizaire R (1986) Arsenic exposure followed by the development of dermatofibrosarcoma protuberans. Cancer 58: 1585-1587.Google Scholar
  48. 48.
    Yu HS, Chiou KS, Chen GS, Yang RC, Chang SF (1993) Progressive alterations of cytokeratin expressions in the process of chronic arsenism. J Dermatol 20: 741-745.Google Scholar
  49. 49.
    Guo H-R, Valberg PA (1997) Evaluation of the validity of the US EPA's cancer risk assessment for arsenic for low-level exposures: A likelihood ratio approach. Environ Geochem Health 19: 133-141.Google Scholar
  50. 50.
    Environmental Protection Agency (2001) National primary drinking water regulations: Arsenic and clarifications to compliance and new source contaminants monitoring; Final rule. Fed Reg 66: 6976-7066.Google Scholar
  51. 51.
    Lu F-J, Guo H-R, Chiang H-S, Hong C-L (1986) Relationships between the fluorescent intensity of well water and the incidence rate of bladder cancer. J Chinese Oncol Soc 2: 134-143.Google Scholar
  52. 52.
    Marcus WL, Rispin AS (1988) Threshold carcinogenicity using arsenic as an example. In: Cothern CR, Mehlman MA, Marcus WL, eds. Advanced Modern Environmental Toxicology, vol. XV: Risk Assessment and Risk Management of Industrial and Environmental Chemicals. Princeton, NJ: Princeton Publishing Co.Google Scholar
  53. 53.
    Uthus EO (1992) Evidence for arsenic essentiality. Environ Geochem Health 14: 55-58.Google Scholar
  54. 54.
    Mayer DR, Kosmus W, Pogglitsch H, Mayer D, Beyer W (1993) Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biol Trace Elem Res 37: 27-38.Google Scholar
  55. 55.
    Störer G (1991) Arsenic: opportunity for risk assessment. Arch Toxicol 65: 525-531.Google Scholar
  56. 56.
    Marczynski B (1988) Careinogenesis as the result of the deficiency of some essential trace elements. Med Hypoth 26: 239-249.Google Scholar
  57. 57.
    Karagas MR, Stukel TA, Morris JS, et al. (2001) Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153: 559-565.Google Scholar
  58. 58.
    Guo H-R (1997) Arsenic in drinking water and skin cancer: comparison among studies based on cancer registry, death certificates, and physical examinations. In: Abernathy CO, Cothern CR, Chappell WR, eds. Arsenic: Exposure and Health Effects. London: Chapman & Hall, pp. 234-259.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • How-Ran Guo
    • 1
  • Hsin-Su Yu
    • 2
  • Howard Hu
    • 3
    • 4
  • Richard R. Monson
    • 3
  1. 1.Graduate Institute of Environmental and Occupational Health, College of MedicineNational Cheng Kung UniversityTainanTaiwan
  2. 2.Department of Dermatology, Medical CollegeKaohsiung Medical UniversityKaohsiungTaiwan
  3. 3.Department of Environmental HealthHarvard School of Public HealthBostonUSA
  4. 4.Channing Laboratory, Department of Medicine, Brigham and Women's HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations